BioSpecifics Technologies Corp.
|
|
|
|
|
developed injectable collagenase for eleven clinical indications; including the following three lead indications: Dupuytren's disease; Peyronie's disease and Frozen Shoulder (adhesive capsulitis) | |
Korean Distributor : ??? |
Products information :
|
|
|
|
|
|
|
|
|
|